Scienion
Frauke Hein is an accomplished executive with extensive experience in the biotechnology and healthcare sectors. Currently serving as the Chief Executive Officer of SCIENION since June 2022, Hein also contributes as an Advisory Board Member at the InfectoGnostics Research Campus Jena and as a Jury Member for the Innovationspreis Berlin Brandenburg. With a history of leadership roles, including Chief Business Officer and cofounder at Adrenomed AG and Director of Portfolio Management at Deutsche Biotech Innovativ AG, Hein has a strong track record in strategic business development, R&D coordination, and managing innovative projects in life sciences. Educational achievements include a PhD in Biotechnology and Biochemistry of Plants and a Diploma in Biology, both from the University of Münster.
This person is not in any teams
This person is not in any offices
Scienion
SCIENION AG is a life science company well positioned in the markets of ultra-low volume liquid handling systems and microarray technologies. They provide their customers with an integrated product portfolio facilitating and improving multiparallel bioanalytics, high throughput screening and high throughput production of microarrays in the genomicsand proteomics fields – from early research to manufacturing.